University of Minnesota: Masonic Cancer Center

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma	Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Stomatognathic Diseases, mouth disorder, neoplasm, salivary gland cancer, salivary gland carcinoma, salivary gland disorder	Active, not recruiting	Phase 2	2026-07-10		NCT03942653
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer	Cognition Disorders, Cognitive Dysfunction, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Cancer, Castration-Resistant, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, brain disorder, central nervous system disorder, cognitive disorder, dementia, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, nervous system disorder, prostate cancer, prostate disorder, psychiatric disorder	Active, not recruiting	Phase 4	2026-02-24		NCT03016741

Clinical trials